UPDATED May 02, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$397.84 | -0.3% | 30.3% | US$2.9t | US$476.52 | PE34.3x | E12.6% | 0.8% | Software | ||
GOOGL | US$166.62 | 6.8% | 59.2% | US$2.0t | US$189.97 | PE25x | E12.2% | 0.5% | Media | ||
AMZN | US$184.72 | 6.4% | 77.6% | US$1.9t | US$216.40 | PE51x | E21.3% | n/a | Retail | ||
META | US$441.68 | -0.4% | 89.7% | US$1.1t | US$518.35 | PE24.5x | E12.2% | 0.5% | Media | ||
LLY | US$755.91 | 4.3% | 76.4% | US$699.4b | US$848.35 | PE110.9x | E27.0% | 0.7% | Pharmaceuticals & Biotech | ||
2330 | NT$776.00 | -0.8% | 55.2% | NT$20.0t | NT$912.98 | PE23.5x | E16.1% | 1.8% | Semiconductors | ||
AVGO | US$1,238.57 | -7.8% | 96.6% | US$574.0b | US$1,501.46 | PE49.6x | E23.4% | 1.7% | Semiconductors | ||
NOVO B | kr.873.10 | 0.7% | 59.6% | kr.3.9t | kr.904.20 | PE43.4x | E14.6% | 1.1% | Pharmaceuticals & Biotech | ||
JPM | US$191.66 | -0.9% | 42.9% | US$551.0b | US$207.83 | PB1.8x | E-1.3% | 2.4% | Banks | ||
WMT | US$59.71 | -0.8% | 19.0% | US$474.3b | US$65.09 | PE31x | E10.7% | 1.4% | Consumer Retailing | ||
XOM | US$116.24 | -4.2% | 9.6% | US$457.5b | US$131.03 | PE14x | E1.5% | 3.3% | Energy | ||
UNH | US$492.97 | -0.2% | 1.2% | US$445.4b | US$567.36 | PE29.5x | E19.5% | 1.5% | Healthcare | ||
700 | HK$364.40 | 4.6% | 6.3% | HK$3.4t | HK$417.90 | PE27.3x | E15.1% | 0.9% | Media | ||
MA | US$441.10 | -4.5% | 17.3% | US$411.0b | US$512.93 | PE34.6x | E11.7% | 0.6% | Diversified Financials | ||
PG | US$163.84 | 0.8% | 5.4% | US$385.6b | US$170.09 | PE26x | E7.2% | 2.5% | Household | ||
A005930 | ₩77,600.00 | 1.2% | 19.2% | ₩519.1t | ₩102,783.78 | PE26.8x | E23.3% | 1.9% | Tech | ||
JNJ | US$149.92 | 2.1% | -7.5% | US$363.8b | US$173.26 | PE21.1x | E7.0% | 3.3% | Pharmaceuticals & Biotech | ||
HD | US$335.53 | 1.1% | 17.4% | US$329.0b | US$384.85 | PE22x | E4.3% | 2.7% | Retail | ||
MRK | US$128.26 | -1.9% | 9.3% | US$326.3b | US$141.64 | PE140.9x | E24.9% | 2.4% | Pharmaceuticals & Biotech | ||
COST | US$732.44 | 0.4% | 46.8% | US$324.8b | US$775.86 | PE47.8x | E7.5% | 0.6% | Consumer Retailing | ||
ORCL | US$114.96 | 0.06% | 21.0% | US$315.1b | US$136.92 | PE29.7x | E14.6% | 1.4% | Software | ||
600519 | CN¥1,705.00 | -0.3% | -2.6% | CN¥2.1t | CN¥2,157.44 | PE27.5x | E12.7% | 2.9% | Food, Beverage & Tobacco | ||
CVX | US$160.73 | -2.8% | 2.9% | US$294.2b | US$182.81 | PE14.6x | E3.1% | 4.1% | Energy | ||
BAC | US$36.88 | -2.7% | 36.6% | US$289.0b | US$39.95 | PB1.1x | E6.1% | 2.6% | Banks |